Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Recombinant protein- and peptide-based vaccines can deliver large amounts of specific antigens for tailored immune responses. One class of these are protein and peptide nanoclusters (PNCs), which are made entirely from the crosslinked antigen. PNCs leverage the inherent immunogenicity of nanoparticulate antigens while minimizing the use of excipients normally used to create them. In this chapter, we discuss PNC fabrication methods, immunostimulatory properties of nanoclusters observed in vitro and in vivo, and protective benefits of PNC vaccines against influenza and cancer mouse models. We conclude with an outlook on future studies of PNCs and PNC design strategies, as well as their use in future vaccine formulations. © 2020. Springer Nature Switzerland AG.

Citation

Timothy Z Chang, Julie A Champion. Protein and Peptide Nanocluster Vaccines. Current topics in microbiology and immunology. 2021;433:107-130

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 33165870

View Full Text